SIEGALL CLAY B 4
4 · Immunome Inc. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
Immunome Inc.IMNM
SIEGALL CLAY B
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-01-31$7.75/sh+150,000$1,162,500→ 669,636 total
Footnotes (1)
- [F1]The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock.